共 63 条
- [3] Improvement of airflow limitation by fluticasone propionate/salmeterol in chronic obstructive pulmonary disease: what is the specific marker? [J]. FRONTIERS IN PHARMACOLOGY, 2011, 2
- [6] [Anonymous], 2017, REPORT 2017, DOI DOI 10.1016/J.RMED.2008.02.004
- [7] Eosinophils in COPD: just another biomarker? [J]. LANCET RESPIRATORY MEDICINE, 2017, 5 (09) : 747 - 759
- [8] Barrecheguren M, 2015, COPD RES PRACT, V1, P8, DOI 10.1186/s40749-015-0012-z